Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
462.99
+3.78 (0.82%)
At close: Dec 24, 2025, 1:00 PM EST
462.55
-0.44 (-0.10%)
After-hours: Dec 24, 2025, 4:59 PM EST
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
24
Consensus Rating
Buy
Price Target
$494.64
Upside
+6.84%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $460 → $515 | Buy | Maintains | $460 → $515 | +11.23% | Dec 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $516 → $564 | Buy | Maintains | $516 → $564 | +21.82% | Dec 5, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $438 → $516 | Hold → Buy | Upgrades | $438 → $516 | +11.45% | Dec 3, 2025 |
| UBS | UBS | Strong Buy Maintains $553 → $546 | Strong Buy | Maintains | $553 → $546 | +17.93% | Nov 7, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $423 → $415 | Hold | Maintains | $423 → $415 | -10.37% | Nov 4, 2025 |
| Barclays | Barclays | Hold Maintains $408 → $414 | Hold | Maintains | $408 → $414 | -10.58% | Nov 4, 2025 |
| Stifel | Stifel | Hold Maintains $455 → $445 | Hold | Maintains | $455 → $445 | -3.89% | Nov 4, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $439 → $438 | Hold | Maintains | $439 → $438 | -5.40% | Oct 10, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $517 → $530 | Buy | Maintains | $517 → $530 | +14.47% | Oct 8, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $550 → $575 | Strong Buy | Maintains | $550 → $575 | +24.19% | Oct 2, 2025 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $458 → $456 | Hold → Buy | Upgrades | $458 → $456 | -1.51% | Sep 25, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $510 → $475 | Buy | Maintains | $510 → $475 | +2.59% | Sep 11, 2025 |
| Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 3, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $575 → $550 | Strong Buy | Maintains | $575 → $550 | +18.79% | Aug 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $424 → $411 | Hold | Maintains | $424 → $411 | -11.23% | Aug 6, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $558 → $546 | Strong Buy | Maintains | $558 → $546 | +17.93% | Aug 6, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.